Wellstone Center Designation
Muscular Dystrophy Association's Clinical Research Network
Nationwide Children’s Hospital is one of five centers to be part of the Muscular Dystrophy Association's Clinical Research Network to support trials and studies in Duchenne muscular dystrophy (DMD).
From studies at the molecular level to the behavioral level, Neurosciences faculty members are investigating how neurological and neuromuscular disorders and conditions develop and working toward new treatment and prevention options.
Faculty members are investigating the potential of virotherapy to treat brain tumors, developing models of neuromuscular diseases, identifying gene-delivery strategies that cross the blood-brain-barrier and lead clinical trials, including the first human gene therapy trial for Duchenne muscular dystrophy, phase I clinical trial to target limb-girdle muscular dystrophy type 2D and have lead the first national muscular dystrophy newborn screening study.
Clinical researchers at Nationwide Children's Hospital are committed to identifying new approaches for the prevention, diagnosis and treatment of childhood diseases, taking research discoveries from the lab to the patient's bedside.
Browse current Neurosciences research studies being conducted at Nationwide Children’s Hospital.
Duchenne Muscular Dystrophy
Spinal Muscular Atrophy
Traumatic Brain Injury/Concussion
Additional Neuromuscular Disorders
The Heart in Neuromuscular Disease
Wellstone Muscular Dystrophy Cooperative Research Center